Patrick A. J. Haslett

Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

P. Haslett, G. Kaplan, J. Musser, 1999, Journal of immunology.

Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.

A. King, B. Shacklett, T. J. Beadle, 2000, Virology.

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.

D. Nixon, S. M. Donahoe, P. Haslett, 2000, The Journal of infectious diseases.

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

D. Katzenstein, T. Merigan, P. Haslett, 1996, The Journal of infectious diseases.